Clinical Associate Professor, Oncology
N/A
School of Medicine
Clinical Faculty
| Qualification | Year | Awarding Institution | Department | Thesis title (Optional Entry) |
| MSC | 2011 | UNIVERSITY OF NEWCASTLE | ONCOLOGY | PERSONALISED ONCOLOGY |
| MD | 2001 | SEMMELWEIS UNIVERSITY | MEDICINE | CHOLINOMIMETIC TREATMENT IN ALZHEIMERS |
| Period of employment | Employer | Location | Position | |
| From | To | |||
| 2020 | Today | PMC | NICOSIA, CYPRUS | MEDICAL ONCOLOGIST |
| 2012 | Today | AMC | NICOSIA, CYPRUS | LEAD MEDICAL ONCOLOGIST |
| 2013 | Today | St.George & Blue Cross Clinic | PAPHOS, CYPRUS | LEAD MEDICAL ONCOLOGIST |
| 2017 | 2018 | GERMAN ONCOLOGY CENTER | LIMASSOL, CYPRUS | LEAD MEDICAL ONCOLOGIST |
| 2011 | 2012 | ROYAL BOURNEMOUTH HOSPITAL | UNITED KINGDOM | MEDICAL ONCOLOGIST |
| Year | Title | Other authors | Journal and Publisher / Conference |
Vol. | Pages |
| 2020 | Pharmacogenomic testing to guide personalized cancer medicine decisions in private oncology practice: a case study. | Astras, G. et al. | Front. Oncol. | 10 | 521 |
| 2017 | Irreversible electroporation (Nanoknife® treatment) in the field of hepatobiliary surgery: Current status and future perspectives |
Georgios Kourounis Patrick Paul Tabet Demetrios Moris Alexandros Papalambros Evangelos Felekouras Fanourios Georgiades Athanasios Petrou |
JBUON 2017 | 22(1) | 141-149 |
| 2016 | Primary Paraganglioma of the Thyroid Gland: Clinical and Immunohistological analysis with a literature review |
Marios Loizou Julien Fengaly Giannis Panayiotou |
EMJ. 2016 | 1[2] | 101-106 |
| 2015 | Diagnosis and management of isolated pituitary metastasis from adenocarcinoma of unknown origin presenting as loss of libido. | Julien Fengaly | BMJ 2015 Mar 31;2015. | Epub 2015 Mar 31. | |
| 2011 | Isolated CNS relapse in human epidermal growth factor receptor 2-positive esophagogastric cancer: effective treatment with trastuzumab after failure of surgery and radiotherapy. | Tom Geldhart | J Clin Oncol 2011 Aug 6 | 29(23) | e664-5 Epub 2011 Jun 6 |
| 2009 | Glucose intolerance during adjuvant chemotherapy for breast cancer. |
Tamas Hickish David Kerr Peter Thomas |
J Natl Cancer Inst 2009 Apr 24. | 101(7) | 537 Epub 2009 Mar 24. |
| Date | Title | Funded by | Project Role* |
| 2018 - 2020 | Pharmacogenomic testing for personalized cancer | OncoDNA, Belgium & C.A.Papaellinas | Investigator |
| 2019 - 2020 | Non-invasive diagnostics via liquid biopsy | NIPD Genetics | Investigator |
| Period | Organization | Title of Position or Service | Key Activities |
| 2020 - today | Royal McDonald House Charity Cyprus | Oncology Consultant | Advisor and committee member |
| 2019 - today | The Cyprus Brain Tumour Association | Vice president | Advisor and committee member |
| 2017-2019 | Cyprus Anticancer Society | Scientific Member | Advisor and committee member |
| 2018 | Novartis | Oncology Consultant | Advisory Board on Adjuvant Melanoma |